Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1118389 | 0.90 | FFAR3 (0.33) | FFAR3 | |
| SCHEMBL17893065 | 0.84 | FFAR3 (0.38) | FFAR3 | |
| SCHEMBL1655866 | 0.82 | FFAR3 (0.32) | FFAR3 | |
| SCHEMBL11793779 | 0.79 | — | — | |
| SCHEMBL11643054 | 0.74 | FFAR3 (0.35) | FFAR3 | |
| SCHEMBL11525220 | 0.72 | — | — | |
| SCHEMBL31360494 | 0.71 | FFAR3 (0.31) | FFAR3 | |
| SCHEMBL1012168 | 0.67 | FFAR3 (0.31) | FFAR3 | |
| SCHEMBL11405241 | 0.67 | IDH1 (0.36) | — | |
| SCHEMBL17732050 | 0.67 | USP2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15429 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-12551465-B2 | Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition | CELLTRION INC. (KR) | 2026-02-17 | — | — | US | claimed |
| EP-4480953-B1 | TYK2 INHIBITORS AND USES THEREOF | ALUMIS INC (US) | 2026-02-04 | — | — | EP | claimed |
| EP-4461734-B1 | TYK2 INHIBITORS AND USES THEREOF | ALUMIS INC (US) | 2026-02-04 | — | — | EP | claimed |
| US-12421264-B2 | Compounds and methods for the treatment of pathogenic Neisseria | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2025-09-23 | — | — | US | claimed |
| US-12414932-B2 | Arsinothricin and methods of treating infections using arsinothricin | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-09-16 | — | — | US | claimed |
| US-20250241885-A1 | ARSINOTHRICIN AND METHODS OF TREATING INFECTIONS USING ARSINOTHRICIN | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-07-31 | — | — | US | claimed |
| CN-115297858-B | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using the same | 赛特瑞恩股份有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-115518071-B | Application of compound in preparation of anti-esophageal cancer drugs | 中国人民解放军联勤保障部队第九〇一医院 | 2024-03-19 | — | — | CN | claimed |
| EP-4320094-A1 | NOVEL MODULATORS OF THE MELATONIN RECEPTORS AS WELL AS METHOD OF MANUFACTURE AND USES THEREOF | Cosmas Therapeutics Development Inc. (CA) | 2024-02-14 | — | — | EP | claimed |
| US-8367732-B2 | Di-fluoro containing compounds as cysteine protease inhibitors | VIROBAY, INC. (US) | 2013-02-05 | — | — | US | claimed |
| EP-2526771-A1 | Inhibitors of bruton's tyrosine kinase | Pharmacyclics, Inc. (US) | 2012-11-28 | — | — | EP | claimed |
| EP-2511257-A2 | Alpha ketoamide compounds as cysteine protease inhibitors | ViroBay, Inc. (US) | 2012-10-17 | — | — | EP | claimed |
| US-20120190714-A1 | ALPHA KETOAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | APPLERA CORPORATION (US) | 2012-07-26 | — | — | US | claimed |
| US-8158786-B2 | Inhibitors of Bruton's tyrosine kinase | PHARMACYCLICS, INC. (US) | 2012-04-17 | — | — | US | claimed |
| US-8101627-B2 | Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses | RIGEL PHARMACEUTICALS, INC. (US) | 2012-01-24 | — | — | US | claimed |
| EP-1943219-B1 | 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS | AMIRA PHARMACEUTICALS INC (US) | 2011-10-26 | — | — | EP | claimed |
| US-20110257203-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | Phamarcyclics, Inc. (US) | 2011-10-20 | — | — | US | claimed |
| EP-1824489-B1 | STEREOISOMERICALLY ENRICHED 3-AMINOCARBONYL BICYCLOHEPTENE PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES | RIGEL PHARMACEUTICALS INC (US) | 2011-01-05 | — | — | EP | claimed |
| US-20090137589-A1 | Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses | RIGEL PHARMACEUTICALS, INC. (US) | 2009-05-28 | — | — | US | claimed |